MapNeuro

MapNeuro is a private neuroscience biotechnology company developing an in vivo discovery platform based on molecular methods that map brain-wide neuronal connectivity and gene expression at cellular resolution. The company originated as a Cold Spring Harbor Laboratory spinout and commercialized molecular connectomics technology developed in the laboratory of Anthony Zador. In addition to offering end-to-end MAPseq and related connectomics services, MapNeuro has stated that it is using its platform to build discovery capabilities for neurodegenerative and psychiatric diseases. Public descriptions emphasize platform and discovery work rather than named therapeutic assets in clinical development. The company appears to be an early-stage, private, platform-focused biotech operating from Cold Spring Harbor, New York.